Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$6.01M Buy
95,653
+214
+0.2% +$13K 0.95% 41
2016
Q4
$5.36M Sell
95,439
-2,649
-3% -$155K 0.88% 46
2016
Q3
$5.84M Sell
98,088
-486
-0.5% -$28.4K 0.98% 38
2016
Q2
$5.42M Buy
98,574
+3,052
+3% +$162K 0.92% 44
2016
Q1
$4.82M Buy
95,522
+3,412
+4% +$167K 0.84% 47
2015
Q4
$4.64M Buy
92,110
+706
+0.8% +$35.6K 0.81% 47
2015
Q3
$4.31M Sell
91,404
-141
-0.2% -$7.49K 0.76% 47
2015
Q2
$4.97M Sell
91,545
-1,026
-1% -$57.5K 0.8% 43
2015
Q1
$5.08M Sell
92,571
-4,908
-5% -$278K 0.77% 44
2014
Q4
$5.28M Sell
97,479
-4,701
-5% -$262K 0.81% 46
2014
Q3
$5.78M Sell
102,180
-1,288
-1% -$72.3K 0.96% 41
2014
Q2
$5.71M Buy
103,468
+277
+0.3% +$15.1K 0.94% 46
2014
Q1
$5.59M Sell
103,191
-10,052
-9% -$521K 0.96% 44
2013
Q4
$5.41M Sell
113,243
-2,097
-2% -$95.9K 0.93% 41
2013
Q3
$5.24M Buy
115,340
+2,672
+2% +$122K 0.97% 36
2013
Q2
$4.99M Buy
+112,668
New +$5.03M 0.95% 38

Other funds holding MRK

Beacon Trust's MRK Position: Q1 2017 in Review

Beacon Trust increased its Merck (MRK) stake by 0.22% in Q1 2017, buying an estimated $13K and bringing the position to 95,653 shares worth $6.01M. The position accounts for 0.95% of the portfolio, ranked #41.

Beacon Trust first reported a position in MRK in Q2 2013 and has held it in 16 quarters since. 1,941 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

  • Beacon Trust held 95,653 shares of Merck worth $6.01M as of Q1 2017.
  • Beacon Trust bought 214 Merck shares in Q1 2017, an estimated $13K.
  • Merck made up 0.95% of Beacon Trust's portfolio in Q1 2017, its #41 holding.
  • Beacon Trust first reported a position in Merck in Q2 2013 and has held it in 16 quarters since.
  • 1,941 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on Beacon Trust's 13F filing for Q1 2017, filed 9 May 2017.